Philips initiated a recall in November of a software application from its subsidiary Braemar Manufacturing after identifying failures to properly route some electrocardiogram (ECG) events.
The US FDA has designated the recall class I, its most serious, and says it...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?